辽宁医学杂志2024,Vol.38Issue(4) :1-4.

兰索拉唑治疗消化性溃疡的临床研究进展

Advances in lansoprazole in the treatment of peptic ulcer

赵心悦 张梓菁 杨丰帆 韩东河 金梅花
辽宁医学杂志2024,Vol.38Issue(4) :1-4.

兰索拉唑治疗消化性溃疡的临床研究进展

Advances in lansoprazole in the treatment of peptic ulcer

赵心悦 1张梓菁 1杨丰帆 1韩东河 1金梅花1
扫码查看

作者信息

  • 1. 大连大学医学院(辽宁大连 116622)
  • 折叠

摘要

消化性溃疡主要指发生于胃和十二指肠的慢性溃疡,临床症状如中上腹痛和反酸,呈周期性和节律性发作.质子泵抑制剂兰索拉唑作用于H+-K+-ATP酶系统,透过壁细胞膜转化为次磺酸和次磺酰衍生物,能调整患者的胃内酸碱值,抑制幽门螺杆菌的活性,具有较高的药物安全性,可以作为临床上治疗消化性溃疡的首选药物.因此文章拟对兰索拉唑的作用机制,对消化性溃疡的治疗作用,联合其他药物治疗消化性溃疡的最新研究进展进行综述,以期为临床用药提供参考.

Abstract

Peptic ulcers are mainly chronic ulcers that occur in the stomach and duodenum,with clinical symptoms such as upper and middle abdominal pain and acid reflux,with periodic and rhythmic episodes.The proton pump inhibitor lanso-prazole acts on the H+-K+-ATPase system and is converted into hyposulfonic acid and hyposulfhydryl derivatives through the mural cell membrane,which can adjust the acid-base value in the patient's stomach and inhibit the activity of Helicobacter pylori,with high drug safety,and can be used as the drug of choice in the clinical treatment of peptic ulcer.Therefore,the arti-cle intends to review the mechanism of action of lansoprazole,its therapeutic effect on peptic ulcer,and the latest research pro-gress of combining with other drugs for the treatment of peptic ulcer,in order to provide reference for clinical use.

关键词

兰索拉唑/消化性溃疡/幽门螺杆菌/研究进展

Key words

Lansoprazole/Peptic ulcer/Helicobacter pylori/Research Progress

引用本文复制引用

出版年

2024
辽宁医学杂志
辽宁省医学会

辽宁医学杂志

影响因子:0.339
ISSN:1001-1722
段落导航相关论文